The DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.
Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4
Abstract
Since 2000, Escherichia coli producing CTX-M enzymes have emerged worldwide as important causes of community-onset urinary tract and bloodstream infections owing to extended-spectrum beta-lactamase (ESBL)-producing bacteria. Molecular epidemiological studies suggested that the sudden worldwide increase of CTX-M-15-producing E. coli was mainly due to a single clone (ST131) and that foreign travel to high-risk areas, such as the Indian subcontinent, might in part play a role in the spread of this clone across different continents. Empirical antibiotic coverage for these resistant organisms should be considered in community patients presenting with sepsis involving the urinary tract, especially if the patient recently travelled to a high-risk area. If this emerging public health threat is ignored, it is possible that the medical community may be forced, in the near future, to use carbapenems as the first choice for the empirical treatment of serious infections associated with urinary tract infections originating from the community.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The molecular epidemiology of the ESBL-E enzymes identified in the Madagascar (Chereau et al., 2015), Nigeria (Fortini et al., 2015), Cameroon (Djuikoue et al., 2016b), and Mozambique (Sáez-lópez et al., 2016) studies was in keeping with the global predominance of the CTX-M clone, which is also widely reported in community-acquired UTI (Pitout et al., 2005;Peirano and Pitout, 2010;Pallecchi et al.”
From Maternal colonization or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Africa: A systematic review and meta-analysis (2017) · cites this paper as Peirano and Pitout, 2010
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,203
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
Self-citationGrowing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,294
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,149
Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D. N., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,121
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A. A., Strahilevitz, J., Jacoby, G. A., Macielag, M. J., Abbanat, D., Park, C. H., Bush, K., & Hooper, D. C. (2005) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,011
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Cantón, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J. A., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon‐Guibout, V., Demarty, R., Alonso, M. P., Caniça, M., Park, Y. J., Lavigne, J., Pitout, J. D. D., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 815
Self-citationEmergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Self-citationCoque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J. D. D., Peixe, L. M. S. V., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1402.070350 · Cited by 702
Self-citationPrevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
Cantón, R., Novais, Â., Valverde, A., Machado, E., Peixe, L. M. S. V., Baquero, F., & Coque, T. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01850.x · Cited by 599
The spread of CTX-M-type extended-spectrum β-lactamases
Rossolini, G. M., D'Andrea, M. M., & Mugnaioli, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01867.x · Cited by 487
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J. F., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Tumbarello, M., Sanguinetti, M., Montuori, E. A., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D’Inzeo, T., Fadda, G., Cauda, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-06 · Cited by 459
Schwaber, M. J., Navon‐Venezia, S., Kaye, K. S., Ben‐Ami, R., Schwartz, D. A., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 414
Edelstein, M. V., Pimkin, M., Palagin, I. S., Edelstein, I. A., & Stratchounski, L. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3724-3732.2003 · Cited by 408
Boyd, D. A., Tyler, S. D., Christianson, S., McGeer, A., Muller, M. P., Willey, B. M., Bryce, E., Gardam, M. A., Nordmann, P., & Mulvey, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3758-3764.2004 · Cited by 389
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 361
Poirel, L., Decousser, J., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 356
Clermont, O., Dhanji, H., Upton, M., Gibreel, T. M., Fox, A., Boyd, D. A., Mulvey, M. R., Nordmann, P., Ruppé, É., Sarthou, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp194 · Cited by 356
Prevalence and clonality of extended-spectrum β-lactamases in Asia
Hawkey, P. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01855.x · Cited by 289
Woodford, N., Carattoli, A., Karisik, E., Underwood, A. P., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 285
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284
Johnson, J. R., Menard, M. L., Johnston, B., Kuskowski, M. A., Nichol, K. A., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Laupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M., & Pitout, J. D. D. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.034 · Cited by 238
Self-citationLewis, J. S., Herrera, M., Wickes, B. L., PATTERSON, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 228
IS Ecp1B -Mediated Transposition of bla CTX-M in Escherichia coli
Poirel, L., Lartigue, M.-F., Decousser, J., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.447-450.2005 · Cited by 228
Hawser, S., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 227
Blomberg, B., Jureen, R., Manji, K. P., Tamim, B. S., Mwakagile, D., Urassa, W. K., Fataki, M. R., Msangi, V., Tellevik, M. G., Maselle, S. Y., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.745-749.2005 · Cited by 226
Fang, H., Ataker, F., Hedin, G., & Dornbusch, K. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01943-07 · Cited by 210
Oteo, J., Navarro, C., Cercenado, E., Delgado‐Iribarren, A., Wilhelmi, I., Orden, B., García, C., Migueláñez, S., Pérez-Vázquez, M. D., García-Cobos, S., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00447-06 · Cited by 206
Rooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Suzuki, S., Shibata, N., Yamane, K., Wachino, J.-I., Ito, K., & Arakawa, Y. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn463 · Cited by 178
Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, Â., Pérez-Vázquez, M. D., Moyá, B., Miró, E., Coque, T. M., Oliver, A., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.006 · Cited by 172
Talbot et al. (2006 42:657-68)
(2006) · Clinical Infectious Diseases · doi:10.1086/503200 · Cited by 168
Cagnacci, S., Gualco, L., Debbia, E. A., Schito, G. C., & Marchese, A. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Lau, S. H., Kaufmann, M. E., Livermore, D. M., Woodford, N., Willshaw, G. A., Cheasty, T., Stamper, K. E., Reddy, S., Cheesbrough, J., Bolton, F. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn380 · Cited by 162
Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E., & Caniça, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01412-06 · Cited by 160
Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases
Marcadé, G., Deschamps, C., Boyd, A. C., Gautier, V., Picard, B., Branger, C., Denamur, É., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn428 · Cited by 155
Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Christianson, S., Simor, A. E., & Paton, S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1204-1214.2004 · Cited by 152
Extended-spectrum β-lactamases in North America, 1987–2006
Bush, K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01848.x · Cited by 150
Moubareck, C. A., Daoud, Z., Hakimé, N., Hamzé, M., Mangeney, N., Matta, H., Mokhbat, J., Rohban, R., Sarkis, D. K., & Doucet‐Populaire, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3309-3313.2005 · Cited by 148
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Self-citationNovel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins
Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y., & Mine, Y. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1243 · Cited by 145
Ensor, V. M., Shahid, M., Evans, J. T., & Hawkey, P. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl422 · Cited by 143
Leflon‐Guibout, V., Blanco, J., Amaqdouf, K., Mora, A., Guize, L., & Nicolas-Chanoine, M.-H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00734-08 · Cited by 138
Lavollay, M., Mamlouk, K., Frank, T., Akpabie, A., Burghoffer, B., Redjeb, S. B., Bercion, R., Gautier, V., & Arlet, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00150-06 · Cited by 134
Pitout, J. D. D., Church, D. L., Gregson, D. B., Chow, B. L., McCracken, M., Mulvey, M. R., & Laupland, K. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01377-06 · Cited by 125
Self-citationBlanco, M., Alonso, M. P., Nicolas-Chanoine, M.-H., Dahbi, G., Mora, A., Blanco, J. E., López, C., Cortés, P., Llagostera, M., Leflon‐Guibout, V., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp122 · Cited by 123
Novais, Â., Cantón, R., Moreira, R., Peixe, L. M. S. V., Baquero, F., & Coque, T. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01070-06 · Cited by 123
Mugnaioli, C., Luzzaro, F., Luca, F. D., Brigante, G., Perilli, M., Amicosante, G., Stefani, S., Toniolo, A., & Rossolini, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00068-06 · Cited by 121
Genetic support of extended-spectrum β-lactamases
Poirel, L., Naas, T., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01865.x · Cited by 118
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., & André, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp108 · Cited by 117
Prevalence of extended-spectrum β-lactamases in South America
Villegas, M. V., Kattán, J. N., Quinteros, M., & Casellas, J. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01869.x · Cited by 112
Early Dissemination of CTX-M-Derived Enzymes in South America
Radice, M. A., Power, P. P., Conza, J. D., & Gutkind, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.602-604.2002 · Cited by 108
Pomba, C., da Fonseca, J. D., Baptista, B., Correia, J. D., & Martı́nez-Martı́nez, L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00896-08 · Cited by 107
Pitout, J. D. D., Laupland, K. B., Church, D. L., Menard, M. L., & Johnson, J. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4667-4670.2005 · Cited by 102
Self-citationDominance of bla CTX-M within an Australian Extended-Spectrum β-Lactamase Gene Pool
Zong, Z., Partridge, S. R., Thomas, L. C., & Iredell, J. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-08 · Cited by 95
Mamlouk, K., Boubaker, I. B.-B., Gautier, V., Vimont, S., Picard, B., Redjeb, S. B., & Arlet, G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01076-06 · Cited by 94
Pallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., & Rossolini, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4556-4561.2004 · Cited by 94
Moland, E. S., Black, J. A., Hossain, A., Hanson, N. D., Thomson, K. S., & Pottumarthy, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2382-2383.2003 · Cited by 91
Multilocus Sequence Typing: Data Analysis in Clinical Microbiology and Public Health
Sullivan, C. B., Diggle, M. A., & Clarke, S. C. (2005) · Molecular Biotechnology · doi:10.1385/mb:29:3:245 · Cited by 91
Castanheira, M., Mendes, R. E., Rhomberg, P. R., & Jones, R. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0827 · Cited by 88
Yumuk, Z., Afacan, G., Nicolas-Chanoine, M.-H., Sotto, A., & Lavigne, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn181 · Cited by 86
Naseer, U., Haldorsen, B. C., Tofteland, S., Hegstad, K., Scheutz, F., Simonsen, G. S., Sundsfjord, A., & THE NORWEGIAN ESBL STUDY GROUP (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02465.x · Cited by 84
Literacka, E., Bedenić, B., Baraniak, A., Fiett, J., Tonkić, M., Jajić-Benčić, I., & Gniadkowski, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01431-08 · Cited by 73
Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-09 · Cited by 70
Self-citationHawser, S., Bouchillon, S. K., Hoban, D. J., & Badal, R. E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.07.013 · Cited by 67
Extended-spectrum β-lactamases in ambulatory care: a clinical perspective
Rodríguez‐Baño, J., & Navarro, M. D. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01866.x · Cited by 62
Gönüllü, N., Aktaş, Z., Kayacan, Ç. B., Şalcıoğlu, M., Carattoli, A., Yong, D. E., & Walsh, T. R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01974-07 · Cited by 60
Pitout, J. D. D., Campbell, L., Church, D. L., Wang, P. W., Guttman, D. S., & Gregson, D. B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02265-08 · Cited by 58
Self-citationFreeman, J. T., McBride, S., Heffernan, H., Bathgate, T., Pope, C., & Ellis-Pegler, R. B. (2008) · Clinical Infectious Diseases · doi:10.1086/590941 · Cited by 57
Emergence of Enterobacteriaceae Isolates Producing CTX-M Extended-Spectrum β-Lactamase in Austria
Eisner, A., Fagan, E. J., Feierl, G., Kessler, H. H., Marth, E., Livermore, D. M., & Woodford, N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.785-787.2006 · Cited by 55
Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, Â., Pérez-Vázquez, M. D., Moyá, B., Miró, E., Coque, T. M., Oliver, A., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.07.001 · Cited by 51
Non-typhoid Salmonella spp. resistant to cefotaxime
Rossi, A., Lopardo, H. Á., Wolof, M., Picandet, A. M., Marifio, M., Galds, M., Radice, M. A., & Gutkind, G. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.697 · Cited by 50
Gangoué‐Piéboji, J., Miriagou, V., Vourli, S., Tzelepi, Ε., Ngassam, P., & TZOUVELEKIS, L. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.441-443.2005 · Cited by 49
Extended-spectrum β-lactamases in long-term-care facilities
Nicolas-Chanoine, M.-H., & Jarlier, V. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01862.x · Cited by 48
Galas, M., Decousser, J., Breton, N., Godard, T., Allouch, P., & Pina, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-07 · Cited by 47
Mitsuda, T., Muto, T., Yamada, M., Kobayashi, N., Toba, M., Aihara, Y., Itô, A., & Yokota, S. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.3.652-656.1998 · Cited by 45
Lau, S., Cheesborough, J., Kaufmann, M. E., Woodford, N., Dodgson, A. R., Dodgson, K., Bolton, E., Fox, A. J., & Upton, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02733.x · Cited by 37
de Silva, E. M. V., Anayá, J. R. M., Reza, M. T. R., Mejía, E. B. G., Manrique, I. Y. P., Llerena, I. D., & Velandia, D. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1919-1920.2006 · Cited by 26
Successful, multiresistant bacterial clones
Woodford, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm474 · Cited by 26
Touati, A., Benallaoua, S., Djoudi, F., Madoux, J., Brasme, L., & de Champs, C. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2007.715 · Cited by 23
Gupta, V., & Datta, P. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.02.002 · Cited by 18
Cited by
Sorted by citations
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 1,001
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González‐Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 993
Antimicrobial Resistance in Escherichia coli
Poirel, L., Madec, J.-Y., Lupo, A., Schink, A., Kieffer, N., Nordmann, P., & Schwarz, Š. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0026-2017 · Cited by 969
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 901
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akova, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 896
Metadata
- Authors
- Peirano, G., & Pitout, J. D. D.
- Affiliations
- University of Calgary (CA)
- ORCID
- Pitout, Johann D.D.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 35
- Issue
- 4
- Pages
- 316-321
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2087341525
- Cited by
- 443
- References
- 89
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 14 · 2021: 15 · 2020: 18 · 2019: 28 · 2018: 20 · 2017: 18 · 2016: 39 · 2015: 35 · 2014: 49 · 2013: 52 · 2012: 56
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Antimicrobial Agents (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- Escherichia coli, CTX-M, ST131, extended-spectrum beta-lactamase, molecular epidemiology, antimicrobial resistance, urinary tract infection, bloodstream infection, sepsis, international travel, Indian subcontinent, empirical antibiotic therapy, carbapenems
- MeSH terms
- Anti-Bacterial Agents, beta-Lactamases, Disease Outbreaks, Escherichia coli, Escherichia coli Infections, Humans, Travel, Urinary Tract Infections, Bacterial Typing Techniques, Bacteremia, Molecular Epidemiology, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review